首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Wide concentration range investigation of recovery, precision and error structure in liquid chromatography
【24h】

Wide concentration range investigation of recovery, precision and error structure in liquid chromatography

机译:液相色谱回收率,精密度和误差结构的宽浓度范围研究

获取原文
获取原文并翻译 | 示例
           

摘要

Using a typical HPLC assay, the characteristics of recovery, system precision and repeatability were investigated over a wide concentration range. In the presence of a constant amount of typical tablet excipients, the antidiabetic drug glibenclamide was analyzed in the range from 0.24 to 0.005 mg/mL (18 concentration levels, 6 independent sample preparations each). On the basis of a typical concentration for an HPLC glibenclamide assay of 0.2 mg/mL, this corresponds to a relative amount of 120-0.025% label claim. In the range from 120 to 0.075%, the recovery was found to be quite constant and systematically heightened mainly due to the evaporation from vials during centrifuging and the displacement of solvent volume by the added matrix. Both system precision and repeatability remain almost constant in the interval from 120 to 10% at a R.S.D.% of 0.31 and 0.70%, respectively, indicating that the sample preparation is the major error source in this range (0.63%). Between 10 and 0.25%, a linear relationship between the logarithmized concentration and the repeatability was noted. However, for lower amounts close to the limit of quantitation, the R.S.D.% of measurements increases much more distinctly. This increase is caused by a strong rise of the system precision. At this concentration range, system precision and repeatability are not significantly different any longer. This leads to the conclusion that with the injection error being constant the peak integration error becomes the dominating error source at low concentrations, e.g. at concentrations below the five-fold of the LOQ. The results obtained here agree well with earlier published data. As the quantitation limit of 0.05% can be regarded as typical for a pharmaceutical impurity control test, generalizations of these findings from this extensive data set should be possible. In this context, peak integration and improvements of the signal-to-noise ratio are the most promising measures to improve an unsatisfactory precision in LC. (C) 2004 Elsevier B.V. All rights reserved.
机译:使用典型的HPLC测定法,在宽浓度范围内研究了回收率,系统精密度和可重复性的特征。在恒定量的典型片剂赋形剂存在下,抗糖尿病药格列本脲的分析范围为0.24至0.005 mg / mL(18种浓度水平,每种6种独立的样品制剂)。在HPLC格列本脲测定的典型浓度为0.2 mg / mL的基础上,这相当于120%至0.025%的标签声称的相对量。在120%至0.075%的范围内,回收率是相当恒定的,并且系统地提高了回收率,这主要是由于离心过程中小瓶中的蒸发以及所添加基质对溶剂体积的置换。系统精密度和重复性在R.S.D.%分别为0.31和0.70%的范围内从120%到10%几乎保持恒定,这表明样品制备是此范围内的主要误差源(0.63%)。在10和0.25%之间,记录了对数浓度和重复性之间的线性关系。但是,对于接近定量极限的较低量,测量的R.S.D.%会明显增加。这种增加是由于系统精度的大幅提高引起的。在此浓度范围内,系统精度和可重复性不再有显着差异。这得出结论,在注入误差恒定的情况下,峰积分误差在低浓度(例如浓度)下成为主要误差源。浓度低于LOQ的五倍。此处获得的结果与早期发布的数据非常吻合。由于0.05%的定量限可以被认为是药物杂质控制测试的典型值,因此应该有可能从大量数据中对这些发现进行概括。在这种情况下,峰积分和信噪比的改善是提高LC精度不令人满意的最有希望的措施。 (C)2004 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号